Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 491-493

  Vila, Jordi ^a   Ruiz, Joaquim ^a   Goñi, Pilar ^a   Jimenez De Anta, M Teresa ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CIPROFLOXACIN; DNA TOPOISOMERASE; GLUTAMIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; DRUG TARGETING; ENZYME SUBUNIT; ESCHERICHIA COLI; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 0030033421     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.491     Document Type: Article

References (41)

1. Adachi, T., M. Mizuuchi, E. A. Robinson, E. Apella, M. H. O'Dea, M. Gellert, and K. Mizuuchi. 1987. DNA sequence of the Escherichia coli gyrB gene: application of a new sequencing strategy. Nucleic Acids Res. 15:771-784.
2. Adams, D. E., E. H. Shekhtman, E. L. Zechiedrich, M. B. Schmid, and N. R. Cozzarelli. 1992. The role of topoisomerase IV in partitioning bacterial replicons and the structure of catenated intermediates in DNA replication Cell 71:277-288.
3. Belland, R. J., S. G. Morrison, C. Ison, and W. M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol. 14:371-380.
4. Cambau, E., F. Bordon, E. Collatz, and L. Gutmann. 1993. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid. Antimicrob. Agents Chemother. 37:1247-1252.
5. Cohen, S. P., D. C. Hooper, J. S. Wolfson, K. S. Souza, L. M. McMurry, and S. B. Levy. 1988. Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrob. Agents Chemother. 32:1187-1191.
6. Cohen, S. P., L. M. McMurry, D. C. Hooper, J. S. Wolfson, and S. B. Levy. 1989 Cross-resistance to fluoroquinolones in multiple antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob. Agents Chemother. 33:1318-1325.
7. Cullen, M. E., A. W. Wyke, R. Kuroda, and L. M. Fisher. 1989 Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers resistance to 4-quinolones Antimicrob. Agents Chemother. 33:886-894.
8. Ferrero, L., B. Cameron, and J. Crouzet. 1995 Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
9. Ferrero, L., B. Cameron, B. Manse. D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994 Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol Microbiol. 13:641-653
10. Gellert, M. 1981. DNA topoisomerases Annu. Rev. Biochem. 50:879-910.
11. Gellert, M., K. Mizuuchi, M. H. O'Dea, T. Itoh, and J. I. Tomizawa. 1977. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl. Acad. Sci. USA 74:4772-4776.
12. Gellert, M., M. Mizuuchi, M. H. O'Dea, and H. A. Nash. 1976. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. USA 73:3872-3876.
13. Heisig, P., H. Schedletzky, and H. Falkenstein-Paul. 1993. Mutations in gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob Agents Chemother. 37:696-701.
14. Hirai, K., H. Aoyama, T. Irikura, S. Iyobe, and S. Mitsuhashi. 1986. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob. Agents Chemother. 29: 535-538.
15. Hirai, K., H. Aoyama, S. Suzue, T. Irikura, S. Iyobe, and S. Mitsuhashi. 1986 Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob. Agents Chemother. 30:248-253.
16. Hooper, D. C., J. S. Wolfson, M. S. Bozza, and E. Y. Ng. 1992. Genetics and regulation of outer membrane protein expression by quinolone resistance loci nfxB, nfxC, and cfxB. Antimicrob. Agents Chemother. 36:1151-1154.
17. Hooper, D. C., J. S. Wolfson, K. S. Souza, E. Y. Ng, G. L. McHugh, and M. N. Swartz. 1989. Mechanism of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation. Antimicrob. Agents Chemother. 33:283-290
18. Hoshino, K., A. Kitamura, I. Morrissey, K. Sato, J. Kato, and H. Ikeda. 1994. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob. Agents Chemother. 38:2623-2627.
19. Kato, J., Y. Nishimura, R. Imamura, H. Niki, S. Higara, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in Escherichia coli Cell 63:393-404.
20. Kato, J., H. Suzuki, and H. Ikeda. 1992. Purification and characterization of DNA topoisomerase IV in Escherichia coli. J. Biol. Chem. 267:25676-25684.
21. Lobner-Olesen, A., and P. Kuempel. 1992. Chromosomal partitioning in Escherichia coli. J. Bacteriol. 174:7883-7889.
22. Nakamura, S., M. Nakamura, T. Kojima, and H. Yoshida. 1989. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob. Agents Chemother. 33:254-255.
23. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2 National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. Oram, M., and L. M. Fisher. 1991 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using polymerase chain reaction. Antimicrob. Agents Chemother. 35:387-389.
25. Ouabdesselam, S., D. C. Hooper, J. Tankovic, and C. J. Soussy. 1995. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations Antimicrob. Agents Chemother 39:1667-1670.
26. Peng, H., and K. J. Marians. 1993. Decatenation activity of topoisomerase IV during oriC and pBR322 DNA replication in vitro. Proc. Natl. Acad. Sci. USA 90:8571-8575.
27. Peng, H., and K. J. Marians. 1993 Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions. J. Biol. Chem. 268:24481-24490.
28. Reece, R., and A. Maxwell. 1991. DNA gyrase: structure and function. Crit. Rev Biochem. Mol. Biol. 26:335-375.
29. Soussy, C. J., J. S. Wolfson, E. Y. Ng, and D. C. Hooper. 1993. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus. Antimicrob. Agents Chemother. 37:2588-2592
30. Steck, T. R., and K. Drlica. 1984 Bacterial chromosome segregation: evidence for DNA gyrase involvement in decatenation. Cell 36:1081-1088
31. Sugino, A., C. L. Peebles, K. N. Kreuzer, and N. R. Cozzarelli. 1977. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl. Acad Sci. USA 74:4767-4771
32. Swanger, S., and J. Wang. 1987. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase. J. Mol. Biol. 197:729-736
33. Vila, J., J. Ruiz, P. Goñi, A. Marcos, and M. T. Jimenez de Anta. 1995. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 39:1201-1203.
34. Vila, J., J. Ruiz, F. Marco, A. Barcelo, P. Goñi, E. Giralt, and M. T. Jimenez de Anta. 1994. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Chemother. 38:2477-2479.
35. Wang, J. C. 1985. DNA topoisomerases. Annu Rev. Biochem 54:665-692.
36. Wang, J. C. 1991. DNA topoisomerases: why so many?. J. Biol. Chem. 266:6659-6662.
37. Wolfson, J. S., and D. C. Hooper. 1985. The fluoroquinolones structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob. Agents Chemother 28:581-586.
38. Yamagishi, J. I., H. Yoshida, H. Yamayoshi, and S. Nakamura. 1986. Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen. Genet. 204:367-373
39. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
40. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991 Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli Antimicrob. Agents Chemother 35:1647-1650.
41. Yoshida, H., T. Kojima, J. I. Yamagishi, and S. Nakamura. 1988. Quinolone-resistant mutation of the gyrA gene of Escherichia coli Mol. Gen Genet. 211:1-7